Introduction Sandeepa Chauhan, Madhumita Roy Chowdhury, Neerja Gupta, Sheffali Gulati*, BK Thelma #, Anjali Dabral #, Madhulika Kabra Genetic Unit, Department.

Slides:



Advertisements
Similar presentations
Chapter 29 Essential Concepts in Molecular Pathology Companion site for Molecular Pathology Author: William B. Coleman and Gregory J. Tsongalis.
Advertisements

Diagnosis with PCR This is a preparation of DNA. We zoomed in a portion of a gene. We know that two primers, Forward and Reverse, will hybridize at specific.
Implications of Consanguinity for Routine Diagnostic Testing and Development of Specialist Services Teresa Lamb Clinical Scientist Leeds DNA Laboratory.
Discuss the relationship between phenotype and genotype in Fragile X syndrome. Louise Williams 06/03/2008.
SP5 -Validation of Methylation Specific PCR for the detection for large FMR-1 expansion mutations in males and females Stacey Mutch East Midlands Regional.
Assessment of a high-throughput DNA melting analysis assay for rapid screening of gene variants in the ornithine transcarbamylase gene K. Sumner*, L. Hubley*,
Fragile X Syndrome (Martin-Bell Syndrome)
DNA marker analysis Mrs. Stewart Medical Interventions Central Magnet School.
DNA Fingerprinting Sotheavy Vann. What is DNA Fingerprinting?  “The generation of a set of distinct DNA fragments from a single DNA sample”  Aka DNA.
Fragile x syndrome By Jordon Nagel.
Fragile X Laboratory Testing: Background and Quality Improvement Opportunities (part 1 of 2) Elaine Lyon, Ph.D. University of Utah/ARUP Laboratories Association.
Male ? Female Breast Cancer Grandma Colon Cancer Female Breast Cancer Male Colon Cancer Female Breast Cancer Female Breast Cancer Male Colon Cancer Male.
Amplification and Detection of DNA Sequences
Variants of PCR Lecture 4
DR. ERNEST K. ADJEI FRCPath. DEPARTMENT OF PATHOLOGY SMS-KATH
Investigating the use of Multiple Displacement Amplification (MDA) to amplify nanogram quantities of DNA to use for downstream mutation screening by sequencing.
Fragile X Brianna Stobbe 3/6/13 Period 4. Common and scientific name: fragile X syndrome (FXS) Other names: Martin-Bell syndrome,Marker X syndrome, FRAXA.
Targeted gene alteration in Caenorhabditis elegans by gene conversion Peter L Barrett, John T Fleming & Verena Göbel Nat Genet Oct 24.
A RAPID AND INNOVATIVE METHOD FOR THE IDENTIFICATION OF THE COMMONEST G6PD ITALIAN MUTATIONS A. Minucci, L. Gentile, S. Rocchetti, C. Zuppi, B. Giardina.
A Multicentre Technology Assessment of the Abbott Fragile X Assay CMGS Spring Meeting 3 rd April Liverpool.
Fragile X Syndrome.
Problem 1 Among 4.5 million births in one population during a period of 40 years, 41 children diagnosed with the autosomal dominant condition aniridia.
FRAGILE X SYNDROME (FXS)
Biotech. Southern Blotting Through a series of steps, DNA that has been separated by electrophoresis is applied to a membrane of nylon or nitrocellulose.
Plant Breeding Shree Krishna Adhikari ©Shree Krishna Adhikari.
DNA marker analysis Mrs. Stewart Medical Interventions Central Magnet School.
© 2013 Pearson Education, Inc. Extensions of Mendelian Genetics  Incomplete Dominance is when a heterozygote expresses a phenotype intermediate between.
Unit 1 – Living Cells.  The study of the human genome  - involves sequencing DNA nucleotides  - and relating this to gene functions  In 2003, the.
Higher Human Biology Unit 1 Human Cells KEY AREA 5: Human Genomics.
PCR Polymerase chain reaction. PCR is a method of amplifying (=copy) a target sequence of DNA.
Fragile X Syndrome (FXS)
Probes and screening for disease. Background Genetic disorders are often the result of gene mutations. People with a mutant allele often have a family.
Arun Kumar. B M.Sc 1st Year Biotechnology SSBS
GENETIC MARKERS (RFLP, AFLP, RAPD, MICROSATELLITES, MINISATELLITES)
Polymerase Chain Reaction
An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene  Alessandro Saluto, Alessandro.
Genetic Disorders Fragile-X Syndrome (FXS) Prevalence
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
Validation of a Commercially Available Screening Tool for the Rapid Identification of CGG Trinucleotide Repeat Expansions in FMR1  Grace X.Y. Lim, Yu.
Volume 1, Issue 6, Pages (May 1998)
STEVE S. SOMMER, M.D., Ph.D.  Mayo Clinic Proceedings 
Laila C. Schenkel, Charles Schwartz, Cindy Skinner, David I
A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk.
Applied Molecular Genetics Molecular Marker and Technique
A Pseudo-Full Mutation Identified in Fragile X Assay Reveals a Novel Base Change Abolishing an EcoRI Restriction Site  Shujian Liang, Harold N. Bass,
Forensic Biology by Richard Li
Expansion of an FMR1 Grey-Zone Allele to a Full Mutation in Two Generations  Isabel Fernandez-Carvajal, Blanca Lopez Posadas, Ruiqin Pan, Christopher Raske,
Modification of the triplet repeat primed polymerase chain reaction method for detection of the CTG repeat expansion in myotonic dystrophy type 1: application.
Bruce E. Hayward, Karen Usdin  The Journal of Molecular Diagnostics 
Performance Evaluation of Two Methods Using Commercially Available Reagents for PCR-Based Detection of FMR1 Mutation  Jane S. Juusola, Paula Anderson,
A Single Nucleotide Variant in the FMR1 CGG Repeat Results in a “Pseudodeletion” and Is Not Associated with the Fragile X Syndrome Phenotype  Massimiliano.
Fragile X Syndrome The Journal of Molecular Diagnostics
Bruce E. Hayward, Yifan Zhou, Daman Kumari, Karen Usdin 
Thomas W. Prior, Scott J. Bridgeman 
An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene  Alessandro Saluto, Alessandro.
Defining the Performance Parameters of a Rapid Screening Tool for FMR1 CGG-Repeat Expansions Based on Direct Triplet-Primed PCR and Melt Curve Analysis 
Polymerase Chain Reaction (PCR)
Reliable and Sensitive Detection of Fragile X (Expanded) Alleles in Clinical Prenatal DNA Samples with a Fast Turnaround Time  Sara Seneca, Willy Lissens,
Screening for Expanded Alleles of the FMR1 Gene in Blood Spots from Newborn Males in a Spanish Population  Isabel Fernandez-Carvajal, Paulina Walichiewicz,
An Information-Rich CGG Repeat Primed PCR That Detects the Full Range of Fragile X Expanded Alleles and Minimizes the Need for Southern Blot Analysis 
Comprehensive Mutation Analysis of the CYP21A2 Gene
Survival of Male Patients with Incontinentia Pigmenti Carrying a Lethal Mutation Can Be Explained by Somatic Mosaicism or Klinefelter Syndrome    The.
A Simple, High-Throughput Assay for Fragile X Expanded Alleles Using Triple Repeat Primed PCR and Capillary Electrophoresis  Elaine Lyon, Thomas Laver,
Single-Molecule Sequencing: Towards Clinical Applications
A Novel Methylation PCR that Offers Standardized Determination of FMR1 Methylation and CGG Repeat Length without Southern Blot Analysis  Marina Grasso,
Novel Polymorphism in the FMR1 Gene Resulting in a “Pseudodeletion” of FMR1 in a Commonly Used Fragile X Assay  Thomas M. Daly, Arash Rafii, Rick A. Martin,
Restriction Fragment Length Polymorphism (RFLP)
Demethylation, Reactivation, and Destabilization of Human Fragile X Full-Mutation Alleles in Mouse Embryocarcinoma Cells  Doris Wöhrle, Ulrike Salat,
FRAGILE X SYNDROME (FXS)
Extra Alleles in FMR1 Triple-Primed PCR
Presentation transcript:

Introduction Sandeepa Chauhan, Madhumita Roy Chowdhury, Neerja Gupta, Sheffali Gulati*, BK Thelma #, Anjali Dabral #, Madhulika Kabra Genetic Unit, Department of Pediatrics, *Department of Pediatrics, AIIMS, New Delhi # Department of Genetics, University of Delhi South Campus, New Delhi Fragile X syndrome is the most common inherited mental impairment, affecting roughly 1 in 4,000 males and 1 in 7,000 females, arising from expansion of CGG repeats in the FMR1 gene. Our laboratory strategy was to do initial screening by PCR method and to test PCR positive cases and family members including at-risk females by Southern blotting. Recently, we have started using AmplideX FMR1 PCR kit to validate our results. Eight patients clinically diagnosed with Fragile X Syndrome were screened by PCR. Southern blotting was done to confirm the result and to detect the carrier status of 25 females in these eight families. AmplideX FMR1 PCR Kit was used to detect the accurate size of alleles up to 200 CGG. Out of eight males, all were found to be affected by all three techniques used. Out of 25 females, full mutation (FM) was found in 3, premutation (PM) in 13 and 9 females were normal Fragile X arises from expansion of CGG repeats in the FMR1 gene. Generally, in normal individuals there are 28 to 32 repeats. Expansions between 55 to 200 (PM) are associated with autism spectrum disorders, reproductive disorders in females (FXPOI), and cognitive/motor disorders in both older males and females (FXTAS). An expansion of repeats to >200 (FM) results in inactivation of the gene through methylation of CpG islands. Applying AmplideX FMR1 PCR Kit to detect the actual number of CGG repeats in the FMR1 gene to identify the carrier status of females and validating the results with Southern blot. Eight patients clinically diagnosed with Fragile X Syndrome were initially screened by PCR. Southern blotting was done to confirm the result and to detect the carrier status of 25 females in these eight families. AmplideX FMR1 PCR Kit was further used to detect the accurate size of alleles up to 200 CGG, identification of FM alleles >200 CGG and a characteristic product peak profile that resolves zygosity in females samples. FMR1 Gene PCR amplification In PCR simultaneous amplification of FRAXA and FRAXE triplet repeats is carried out using 100 ng of DNA in 25 µL reaction Results 5.2Kb Southern Blot PM N – Normal FM – Full mutation PM – Pre mutation Southern blotting was done by using PstI enzyme for Premutation and EcoRI and EagI for Full mutation N N FM N FM FM N N AmplideX ™ FMR1 PCR Kit Protocol The test protocol involves three key sets of procedures: PCR master mix setup and thermal cycling Capillary electrophoresis Fragment sizing analysis Conversion peak size to CGG repeat length After capillary electrophoresis, the size of the target amplicon is derived from comparison to a co-injected size standard, e.g. ROX 1000 Size Ladder The AmplideX FMR1 PCR Kit incorporates two correction factors for conversion of size in base pairs to the number of CGG repeats for each allele The size of each peak may be converted to repeat length by the equation Peak i - size in base pairs of a given product peak, c 0 - size correction factor, m 0 - mobility correction factor for each CGG repeat Size and mobility correction factors for standard instrument configurations Configurationc0c0 m0m0 3130, 36 cm Data interpretation Normal male with no AGG interruption Female with two normal X AGG interruption in both X in 2 locations 29 CGG Female 29/29 CGG homozygous Male FM mosaic with all peak populations >200 Premutation78 CGG 125 CGG 108 CGG Premutation Female CGG Female heterozygous Normal/FM with 2 AGG interruption FM >200 AGG interruption Two X, with one normal X and one pre-mutation mosaic X. 2 AGG interruptions on 1 X Total families screened :8 Total no. of females: 25 PCR Positive Confirmed by southern blotting Confirmed by AmplideX FMR1 PCR Kit Confirmed by southern blotting Confirmed by AmplideX FMR1 PCR Kit Full Mutation:3 Premutation: 13 Normal: 9 S noPCRSouthern BlottingAmplideX FMR1 1Unable to detect pre mutation Unable to detect full mutation in females Can not interpret accurate CGG repeats, Can not detect interrupting AGG sequences accurately detects full mutations having 200 CGG repeats to 1300 Can detect interrupting AGG sequences resolves female zygosity 2No radioisotopesUsage of radioisotopes, which are hazardous No radioisotopes 3Easy to performLabor intensiveEasy to perform 4RapidTime consumingLess time consuming than Southern blotting Comparison of PCR, Southern blotting and AmplideX FMR1 Conclusion The FMR1 CGG Primer is specific for CGG repeats and will not hybridize to AGG sequences commonly found in FMR1 alleles. Signal intensity dips in the CGG RP PCR profile correspond to the presence of interspersed AGG. These AGG “interruptions” are thought to confer DNA stability and to reduce the risk of expansion in the next generation intermediate and PM alleles because AGG “interruptions” are thought to confer DNA stability and to reduce the risk of expansion in the next generation Therefore, the risk of CGG repeat expansion for mothers with AGG “interruptions” may be lower than mothers with the same number of repeats but without at least one AGG. Hence helpful in genetic counselling in the families with Fragile X Abstract Objective Material and Methods 2 pairs of primers, 20 pmole of FXD and FXE for amplification of the FRAXA CGG repeat and 35 pmole of 598 and 603 for amplification of FRAXE CCG repeat are used. In a normal individual two distinct bands are be visible, the upper band is of FRAXE and a lower band is of FRAXA. Individual showing absence of any of these bands indicates fragile X positive case. FRAXE positive case is extremely rare thus this band acts as a control band. Total no.of males:8